Skip to main content
Equibles

Allan Douglas Kirk, MD, PhD, FACS

Board Member

Eledon Pharmaceuticals, Inc. (ELDN)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Allan Douglas Kirk, MD, PhD, FACS

Allan Douglas Kirk, MD, PhD, FACS is recorded as Board Member at Eledon Pharmaceuticals, Inc. (ELDN). Eledon Pharmaceuticals, Inc. reported in an 8-K filed October 2, 2023 that Allan Douglas Kirk, MD, PhD, FACS was appointed director, effective October 2, 2023.

“On September 29, 2023, Allan Douglas Kirk, MD, PhD, FACS, was appointed to the board of directors (the "Board") of Eledon Pharmaceuticals, Inc., ("Eledon"), effective October 2, 2023.”
Eledon Pharmaceuticals, Inc. Form 8-K, filed October 2, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Eledon Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.